FLT180a

FLT180a · Spur Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FLT180a, covering 2026-07-31 to 2026-07-31. Get the full timeline:

Most recent: Clinical Trial Results: Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B [Phase 1, Phase 2]